Blood glucose monitors and test strips are product areas that may fall under a competitive bidding model in upcoming Medicare reform legislation, according to device stakeholders

The passage of a Medicare prescription drug benefit in the 108th Congress could lead to the expansion of competitive bidding processes beyond durable medical equipment to include non-DME devices, consultants and industry reps are forecasting

While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.